OTC : TWAPF

Towa Pharmaceutical Co., Ltd.

$26 USD

$0 (0.0%)

Volume
100
Average Volume
3
Market Capitalization
$1.28B
P/E Ratio
39.29
Dividend Yield
1.91%
Price Target
Year High
$26.00
Year Low
$16.83
Day High
—
Day Low
—
Payout Ratio
$0.75
Current Ratio
$2.76
3333332"{? p/.m7yd f,0=

Annual earnings financials

TWAPF financial data with annual/quarterly toggle

TWAPF GAAP EPS - Annual & Quarterly

TWAPF Sales Revenue - Annual & Quarterly

TWAPF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

TWAPF Estimated and Actual Revenue by Quarter
TWAPF Estimated and Actual EPS by Quarter
TWAPF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-03-31 1 14.95B 14.95B 14.95B 7.59B 7.59B 7.59B
2026-12-31 1 15.32B 15.32B 15.32B 7.78B 7.78B 7.78B
2026-09-30 1 13.71B 13.71B 13.71B 6.96B 6.96B 6.96B
2026-06-30 2 13.4B 13.46B 13.43B 6.81B 6.84B 6.82B
2026-03-31 3 14.01B 14.31B 14.2B 7.12B 7.27B 7.21B
2025-12-31 2 14.27B 14.39B 14.33B 7.25B 7.31B 7.28B
TWAPF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-03-31 1 - - - 19.96B 19.96B 19.96B
2026-12-31 1 - - - 20.46B 20.46B 20.46B
2026-09-30 1 - - - 18.3B 18.3B 18.3B
2026-06-30 2 - - - 17.9B 17.98B 17.94B
2026-03-31 3 5.34B 5.34B 5.34B 18.71B 19.11B 18.96B
2025-12-31 2 3.62B 3.62B 3.62B 19.05B 19.21B 19.13B
TWAPF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-03-31 1 78.87B 78.87B 78.87B 0 0 0 0
2026-12-31 1 80.8B 80.8B 80.8B 0 0 0 0
2026-09-30 1 72.31B 72.31B 72.31B 0 0 0 0
2026-06-30 2 70.7B 71.02B 70.86B 0 0 0 0
2026-03-31 3 73.9B 75.48B 74.92B 1 108.56911 108.56911 108.56911
2025-12-31 2 75.27B 75.89B 75.58B 1 73.62444 73.62444 73.62444